430 Design and structure–activity relationships of highly potent and bioavailable imidazolinone FASN KR domain inhibitors
Bruce L Grasberger,Boudewijn Janssens,Tao Lu,Donald William Ludovici,Lieven Meerpoel,Christina Marie Meyer,M A Parker,Danielle Peeters,C Rocaboy,Carsten Schubert,Karine Smans,Erwin Fraiponts,Norbert Esser,S De Breucker,Ronaldus Arnodus Hendrika Joseph Gilissen,Gilles Bignan,Richard S Alexander,James R Bischoff,Maxwell D Cummings,Patricia Connolly European Journal of Cancer(2014)
AI 理解论文
溯源树
样例